Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Health Andishe Sana Pharmaceutical (HASCO) is a prominent Iranian pharmaceutical company based in Tehran that specializes in the development, manufacturing, and distribution of generic medicines and nutritional supplements. The company maintains a diverse portfolio focusing on therapeutic areas such as cardiovascular health, neurology, and metabolic disorders, with a highly recognized line of vitamin and mineral products branded under the Sana name. HASCO operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards to ensure product quality and safety. By leveraging a robust domestic supply chain, the company aims to provide accessible and affordable healthcare solutions to the Iranian market and the broader Middle East region. HASCO continues to expand its reach through the introduction of new generic formulations and specialized health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Andishe Sana Pharmaceutical.